GATEWAY INVESTMENT ADVISERS LLC – Vertex Pharmaceuticals Incorporated Transaction History
GATEWAY INVESTMENT ADVISERS LLC portfolio value:
$22.12M
portfolio value
GATEWAY INVESTMENT ADVISERS LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +7.37% | 5.24K shares | 2.07M | $289.54 | 76.42K |
Q2 2022 | share | Decrease | -18.42% | -16.07K shares | -2.71M | $281.79 | 71.17K |
Q1 2022 | share | Decrease | -2.99% | -2.69K shares | 3.01M | $260.97 | 87.25K |
Q4 2021 | share | Decrease | -12.14% | -12.42K shares | 1.18M | $222.45 | 89.94K |
Q3 2021 | share | Decrease | -0.86% | -884 shares | -2.25M | $181.39 | 102.36K |
Q2 2021 | share | Decrease | -11.08% | -12.86K shares | -4.13M | $201.63 | 103.25K |
Q1 2021 | share | Decrease | -2.19% | -2.60K shares | -3.10M | $214.89 | 116.12K |
Q4 2020 | share | Decrease | -0.58% | -687 shares | -4.43M | $236.34 | 118.72K |
Q3 2020 | share | Decrease | -4.66% | -5.84K shares | -3.86M | $272.12 | 119.41K |
Q2 2020 | share | Decrease | -10.65% | -14.93K shares | 3.00M | $290.31 | 125.25K |
Q1 2020 | share | Decrease | -3.33% | -4.83K shares | 1.60M | $237.95 | 140.18K |
Q4 2019 | share | Increase | +2.31% | 3.27K shares | 7.73M | $218.95 | 145.01K |
Q3 2019 | share | Decrease | -4.52% | -6.70K shares | -3.20M | $169.42 | 141.73K |
Q2 2019 | share | Decrease | -0.17% | -246 shares | -130K | $183.38 | 148.44K |
Q1 2019 | share | Increase | +0.53% | 780 shares | 2.84M | $183.95 | 148.69K |
Q4 2018 | share | Increase | +11.96% | 15.79K shares | -954K | $165.71 | 147.91K |
Q3 2018 | share | Decrease | -0.22% | -290 shares | 2.96M | $192.74 | 132.11K |
Q2 2018 | share | Decrease | -1.85% | -2.50K shares | 516K | $169.96 | 132.40K |
Q1 2018 | share | Decrease | -1.85% | -2.54K shares | 1.38M | $162.98 | 134.90K |
Q4 2017 | share | Decrease | -0.07% | -91 shares | -314K | $149.86 | 137.44K |
Q3 2017 | share | Decrease | -6.92% | -10.22K shares | 1.87M | $152.04 | 137.54K |
Q2 2017 | share | Decrease | -17.99% | -32.41K shares | -661K | $128.87 | 147.76K |
Q1 2017 | share | Increase | +7.68% | 12.85K shares | 7.37M | $109.35 | 180.18K |
Q4 2016 | share | Decrease | -4.93% | -8.68K shares | -3.02M | $73.67 | 167.32K |
Q3 2016 | share | Increase | +1.98% | 3.42K shares | 504K | $87.21 | 176.00K |
Q2 2016 | share | Increase | +6.60% | 10.68K shares | 1.97M | $86.02 | 172.58K |
Q1 2016 | share | Decrease | -0.22% | -365 shares | -7.54M | $79.49 | 161.89K |